At the time of writing, Rockwell Medical Inc [RMTI] stock is trading at $1.71, up 12.50%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RMTI shares have gain 22.14% over the last week, with a monthly amount glided 32.56%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 21, March 2024, Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023. In a post published today on Yahoo Finance, Reports record net sales for second year in a row, generating $83.6 million in 2023, an increase of 15% over 2022. Net sales for the fourth quarter of 2023 were $22.1 million, an increase of 14% over the same period in 2022.
From an analyst’s perspective:
Rockwell Medical Inc [NASDAQ: RMTI] stock has seen the most recent analyst activity on June 24, 2019, when Piper Jaffray initiated its Overweight rating and assigned the stock a price target of $10. Previously, H.C. Wainwright started tracking the stock with Buy rating on May 13, 2019, and set its price target to $11. On November 08, 2016, downgrade downgraded it’s rating to Underperform. Stifel downgraded its rating to a Hold. Morgan Stanley initiated its recommendation with a Underweight and recommended $7 as its price target on August 13, 2015. Oppenheimer reiterated a Outperform rating for this stock on January 27, 2015, and upped its price target to $26. In a note dated January 07, 2015, Oppenheimer initiated an Outperform rating and provided a target price of $24 on this stock.
For the past year, the stock price of Rockwell Medical Inc fluctuated between $1.16 and $6.24. Currently, Wall Street analysts expect the stock to reach $11 within the next 12 months. Rockwell Medical Inc [NASDAQ: RMTI] shares were valued at $1.71 at the most recent close of the market. An investor can expect a potential return of 543.27% based on the average RMTI price forecast.
Analyzing the RMTI fundamentals
According to Rockwell Medical Inc [NASDAQ:RMTI], the company’s sales were 83.61M for trailing twelve months, which represents an 14.39% jump. Gross Profit Margin for this corporation currently stands at 0.1% with Operating Profit Margin at -0.08%, Pretax Profit Margin comes in at -0.1%, and Net Profit Margin reading is -0.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.18, Equity is -0.57 and Total Capital is -0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.49.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5267 points at the first support level, and at 1.3433 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.8067, and for the 2nd resistance point, it is at 1.9033.
Rockwell Medical Inc [RMTI] reported earnings per share of -$0.05 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.07/share, meaning a difference of $0.02 and a surprise factor of 28.60%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.07 per share as compared to estimates of -$0.1 per share, a difference of $0.03 representing a surprise of 30.00%.
Ratios To Look Out For
It is important to note that Rockwell Medical Inc [NASDAQ:RMTI] has a current ratio of 1.73. In addition, the Quick Ratio stands at 1.38 and the Cash Ratio stands at 0.54. Considering the valuation of this stock, the price to sales ratio is 0.60, the price to book ratio is 2.34.
